 The study found that increased access to antiretroviral therapy led to a significant increase in life expectancy among HIV positive patients in Rwanda, with the highest life expectances for those enrolling in care with CD for cell counts of 500 cells per L or more and WHO disease stage I. This article was authored by Sabin in Zanzimana, MD, Eric Remerah, Master of Science, Steve Cantiz, Master of Science and others.